Compositions and use thereof for treating symptoms of preeclampsia
A therapeutic agent for the treatment of toxemia, preeclampsia and eclampsia and a method for preparing the therapeutic agent is disclosed. The therapeutic agent is a stable pharmaceutical preparation containing, but not limited to, digestive/pancreatic enzymes. The therapeutic agent may be manufactured by a variety of encapsulation technologies. Delivery of the therapeutic agent may be made orally, through injection, by adherence of a medicated patch or by other methods. Further, a method of using the presence of chymotrypsin in the maternal GI tract as a biomarker to determine the likelihood of developing preeclampsia, a pregnancy induced hypertension, and eclampsia/toxemia is disclosed.
1. A method for treating an individual having preeclampsia characterized by hypertension, proteinuria, or a combination thereof, comprising administering a preparation of digestive enzymes comprising an amylase, a lipase, and a protease to the individual, wherein the individual having preeclampsia is treated.
2. The method of claim 1 , wherein the protease comprises chymotrypsin, trypsin, papain, or a combination thereof.
3. The method of claim 1 , wherein the digestive enzymes are obtained from a source comprising animal enzymes, plant enzymes, synthetic enzymes, or a combination thereof.
4. The method of claim 1 , wherein the preparation of digestive enzymes is manufactured using a technology selected from the group consisting of enteric coating, lipid encapsulation, direct compression, dry granulation, wet granulation, and a combination thereof.
5. The method of claim 1 , wherein the preparation of digestive enzymes is administered orally via a dosage formulation selected from the group consisting of: pills, tablets, capsules, microcapsules, mini-capsules, time released capsules, mini-tabs, sprinkles, and a combination thereof.
6. The method of claim 1 , wherein the preperation of digestive enzymes comprises amylase in an amount from 10,000 to 60,000 USP units/dose.
7. The method of claim 1 , wherein the preparation of digestive enzymes comprises protease in an amount from 10,000 to 70,000 USP units/dose.
8. The method of claim 1 , wherein the preparation of digestive enzymes comprises lipase in an amount from 4,000 to 30,000 USP units/dose.
9. The method of claim 2 , wherein the chymotrypsin is present in an amount from 2 to 5 mg.
10. The method of claim 2 , wherein the papain is present in an amount from 3,000 to 10,000 USP units/dose.
11. The method of claim 2 , wherein the trypsin is present in an amount from 60 to 100 mg.
12. The method of claim 1 , wherein the total amount of digestive enzymes present is in an amount from about 4,000 to about 176,000 USP/dose.